10
Participants
Start Date
October 15, 2025
Primary Completion Date
July 1, 2026
Study Completion Date
December 31, 2026
Nighttime Deep Brain Stimulation with Varying Amplitude Settings
Participants will undergo three different nighttime-only Deep Brain Stimulation (DBS) settings in a randomized crossover design: 0% amplitude (stimulation off), 50% amplitude of their optimal clinical DBS settings, and full clinical DBS settings (100%). Each setting is applied for two weeks during sleep, over a total six-week home monitoring period. The intervention is designed to assess how varying levels of subthalamic nucleus DBS influence sleep quality and neural oscillatory activity. Only nighttime DBS settings are modified; daytime settings remain unchanged.
RECRUITING
Cleveland Clinic, Cleveland
Collaborators (1)
American Parkinson's Disease Association, Inc
OTHER
Beacon Biosignals
INDUSTRY
The Cleveland Clinic
OTHER